Grant Erdel is named as a lobbyist on federal disclosure filings for 1 client through Glenmark Pharmaceuticals USA. The most recent filing naming them posted in October 2022. Issues reported include Health Issues and Medicare/Medicaid.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| GLENMARK PHARMACEUTICALS USA | GLENMARK PHARMACEUTICALS USA | Q3 2022 | Medicare/Medicaid, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2022 | 1 | 1 |
| 2021 | 1 | 1 |
| 2020 | 1 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Grant Erdel. See the Capitol Clarity rankings and method.